Global Commercial Aquaculture Vaccines 麻豆原创 Research Report 2024

Publication ID:

PB506247354

Publication Date:

June 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Commercial Aquaculture Vaccines Are Approved Vaccines That Can Induce Protective Immune Responses In Aquatic Animals. The Mass Production Of Aquatic Species Leads To Changes In Optimal Breeding Conditions, Which Indicates Increased Sensitivity To Infectious/Viral Diseases, Thereby Increasing Increased Demand For Commercial Aquaculture Vaccines, Bacterial Diseases And Zoonotic Infections, Are Major Obstacles To Successful Aquaculture. Facts Have Proved That Commercial Aquaculture Vaccines Are A Better Alternative To Antibiotics Used In Fish Aquaculture, Because Antibiotic Treatment Has Attracted A Lot Of Attention Due To Adverse Effects Such As Bacterial Resistance, Toxicity, And Residual Antibiotics In Aquaculture Food. In Addition, The Increase In Global Fish Consumption And The Prevalence Of Bacterial Infections Between Aquatic Species Are Also Increasing The Use Of Commercial Fish Aquaculture Vaccines.
The global Commercial Aquaculture Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Commercial Aquaculture Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercial Aquaculture Vaccines.
Report Scope
The Commercial Aquaculture Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Commercial Aquaculture Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Commercial Aquaculture Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Ictyogroup
Tecnovax
Nisseiken Co Ltd
Segment by Type
Nucleic Acid Vaccine
Subunit Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Segment by Application
Fisheries
Breeding Clinic
Fisheries Research Institute
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Commercial Aquaculture Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Commercial Aquaculture Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Commercial Aquaculture Vaccines 麻豆原创 Overview
1.1 Product Overview and Scope of Commercial Aquaculture Vaccines
1.2 Commercial Aquaculture Vaccines Segment by Type
1.2.1 Global Commercial Aquaculture Vaccines 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Nucleic Acid Vaccine
1.2.3 Subunit Vaccine
1.2.4 Live Attenuated Vaccine
1.2.5 Inactivated Vaccine
1.3 Commercial Aquaculture Vaccines Segment by Application
1.3.1 Global Commercial Aquaculture Vaccines 麻豆原创 Value by Application: (2024-2030)
1.3.2 Fisheries
1.3.3 Breeding Clinic
1.3.4 Fisheries Research Institute
1.4 Global Commercial Aquaculture Vaccines 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Commercial Aquaculture Vaccines Revenue 2019-2030
1.4.2 Global Commercial Aquaculture Vaccines Sales 2019-2030
1.4.3 Global Commercial Aquaculture Vaccines 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Commercial Aquaculture Vaccines 麻豆原创 Competition by Manufacturers
2.1 Global Commercial Aquaculture Vaccines Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Commercial Aquaculture Vaccines Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Commercial Aquaculture Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Commercial Aquaculture Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Commercial Aquaculture Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Commercial Aquaculture Vaccines, Product Type & Application
2.7 Commercial Aquaculture Vaccines 麻豆原创 Competitive Situation and Trends
2.7.1 Commercial Aquaculture Vaccines 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Commercial Aquaculture Vaccines Players 麻豆原创 Share by Revenue
2.7.3 Global Commercial Aquaculture Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Commercial Aquaculture Vaccines Retrospective 麻豆原创 Scenario by Region
3.1 Global Commercial Aquaculture Vaccines 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Commercial Aquaculture Vaccines Global Commercial Aquaculture Vaccines Sales by Region: 2019-2030
3.2.1 Global Commercial Aquaculture Vaccines Sales by Region: 2019-2024
3.2.2 Global Commercial Aquaculture Vaccines Sales by Region: 2025-2030
3.3 Global Commercial Aquaculture Vaccines Global Commercial Aquaculture Vaccines Revenue by Region: 2019-2030
3.3.1 Global Commercial Aquaculture Vaccines Revenue by Region: 2019-2024
3.3.2 Global Commercial Aquaculture Vaccines Revenue by Region: 2025-2030
3.4 North America Commercial Aquaculture Vaccines 麻豆原创 Facts & Figures by Country
3.4.1 North America Commercial Aquaculture Vaccines 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Commercial Aquaculture Vaccines Sales by Country (2019-2030)
3.4.3 North America Commercial Aquaculture Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Commercial Aquaculture Vaccines 麻豆原创 Facts & Figures by Country
3.5.1 Europe Commercial Aquaculture Vaccines 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Commercial Aquaculture Vaccines Sales by Country (2019-2030)
3.5.3 Europe Commercial Aquaculture Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Commercial Aquaculture Vaccines 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Commercial Aquaculture Vaccines 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Commercial Aquaculture Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Commercial Aquaculture Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Commercial Aquaculture Vaccines 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Commercial Aquaculture Vaccines 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Commercial Aquaculture Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Commercial Aquaculture Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Commercial Aquaculture Vaccines 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Commercial Aquaculture Vaccines 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Commercial Aquaculture Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Commercial Aquaculture Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Commercial Aquaculture Vaccines Sales by Type (2019-2030)
4.1.1 Global Commercial Aquaculture Vaccines Sales by Type (2019-2024)
4.1.2 Global Commercial Aquaculture Vaccines Sales by Type (2025-2030)
4.1.3 Global Commercial Aquaculture Vaccines Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Commercial Aquaculture Vaccines Revenue by Type (2019-2030)
4.2.1 Global Commercial Aquaculture Vaccines Revenue by Type (2019-2024)
4.2.2 Global Commercial Aquaculture Vaccines Revenue by Type (2025-2030)
4.2.3 Global Commercial Aquaculture Vaccines Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Commercial Aquaculture Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Commercial Aquaculture Vaccines Sales by Application (2019-2030)
5.1.1 Global Commercial Aquaculture Vaccines Sales by Application (2019-2024)
5.1.2 Global Commercial Aquaculture Vaccines Sales by Application (2025-2030)
5.1.3 Global Commercial Aquaculture Vaccines Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Commercial Aquaculture Vaccines Revenue by Application (2019-2030)
5.2.1 Global Commercial Aquaculture Vaccines Revenue by Application (2019-2024)
5.2.2 Global Commercial Aquaculture Vaccines Revenue by Application (2025-2030)
5.2.3 Global Commercial Aquaculture Vaccines Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Commercial Aquaculture Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis LLC
6.1.1 Zoetis LLC Corporation Information
6.1.2 Zoetis LLC Description and Business Overview
6.1.3 Zoetis LLC Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis LLC Commercial Aquaculture Vaccines Product Portfolio
6.1.5 Zoetis LLC Recent Developments/Updates
6.2 Merck & Co. Inc. (MSD Animal Health)
6.2.1 Merck & Co. Inc. (MSD Animal Health) Corporation Information
6.2.2 Merck & Co. Inc. (MSD Animal Health) Description and Business Overview
6.2.3 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co. Inc. (MSD Animal Health) Commercial Aquaculture Vaccines Product Portfolio
6.2.5 Merck & Co. Inc. (MSD Animal Health) Recent Developments/Updates
6.3 Laboratorios Hipra S. A.
6.3.1 Laboratorios Hipra S. A. Corporation Information
6.3.2 Laboratorios Hipra S. A. Description and Business Overview
6.3.3 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Laboratorios Hipra S. A. Commercial Aquaculture Vaccines Product Portfolio
6.3.5 Laboratorios Hipra S. A. Recent Developments/Updates
6.4 Elanco Animal Health Inc
6.4.1 Elanco Animal Health Inc Corporation Information
6.4.2 Elanco Animal Health Inc Description and Business Overview
6.4.3 Elanco Animal Health Inc Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Animal Health Inc Commercial Aquaculture Vaccines Product Portfolio
6.4.5 Elanco Animal Health Inc Recent Developments/Updates
6.5 Veterquimica S. A.
6.5.1 Veterquimica S. A. Corporation Information
6.5.2 Veterquimica S. A. Description and Business Overview
6.5.3 Veterquimica S. A. Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Veterquimica S. A. Commercial Aquaculture Vaccines Product Portfolio
6.5.5 Veterquimica S. A. Recent Developments/Updates
6.6 Ictyogroup
6.6.1 Ictyogroup Corporation Information
6.6.2 Ictyogroup Description and Business Overview
6.6.3 Ictyogroup Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ictyogroup Commercial Aquaculture Vaccines Product Portfolio
6.6.5 Ictyogroup Recent Developments/Updates
6.7 Tecnovax
6.6.1 Tecnovax Corporation Information
6.6.2 Tecnovax Description and Business Overview
6.6.3 Tecnovax Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tecnovax Commercial Aquaculture Vaccines Product Portfolio
6.7.5 Tecnovax Recent Developments/Updates
6.8 Nisseiken Co Ltd
6.8.1 Nisseiken Co Ltd Corporation Information
6.8.2 Nisseiken Co Ltd Description and Business Overview
6.8.3 Nisseiken Co Ltd Commercial Aquaculture Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nisseiken Co Ltd Commercial Aquaculture Vaccines Product Portfolio
6.8.5 Nisseiken Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Commercial Aquaculture Vaccines Industry Chain Analysis
7.2 Commercial Aquaculture Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Commercial Aquaculture Vaccines Production Mode & Process
7.4 Commercial Aquaculture Vaccines Sales and 麻豆原创ing
7.4.1 Commercial Aquaculture Vaccines Sales Channels
7.4.2 Commercial Aquaculture Vaccines Distributors
7.5 Commercial Aquaculture Vaccines Customers
8 Commercial Aquaculture Vaccines 麻豆原创 Dynamics
8.1 Commercial Aquaculture Vaccines Industry Trends
8.2 Commercial Aquaculture Vaccines 麻豆原创 Drivers
8.3 Commercial Aquaculture Vaccines 麻豆原创 Challenges
8.4 Commercial Aquaculture Vaccines 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Ictyogroup
Tecnovax
Nisseiken Co Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.